<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor cerebri</z:e> (PTC) is a seldom seen entity characterized by signs and symptoms associated with the intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IH) without obvious causes </plain></SENT>
<SENT sid="1" pm="."><plain>Some medical disorders and exogenous agents have been implicated in the development of PTC </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="4315">Danazol</z:chebi> is a popular gonadotropin inhibitor used for the treatment of <z:e sem="disease" ids="C0014175" disease_type="Disease or Syndrome" abbrv="">endometriosis</z:e>, <z:e sem="disease" ids="C0006145" disease_type="Disease or Syndrome" abbrv="">breast disease</z:e> and hereditary <z:hpo ids='HP_0100665'>angioedema</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>While PTC has been occasionally reported in patients receiving <z:chebi fb="1" ids="4315">danazol</z:chebi> treatment, it is barely mentioned in those who discontinued <z:chebi fb="1" ids="4315">danazol</z:chebi> therapy abruptly </plain></SENT>
<SENT sid="4" pm="."><plain>Here we report a case of IH developed soon after the withdrawal of <z:chebi fb="1" ids="4315">danazol</z:chebi> </plain></SENT>
</text></document>